OBJECTIVES: To assess the level of awareness of prostate cancer among the general public in Europe and the USA. METHODS: An independent survey was undertaken across six European countries (France, Germany, Italy, Spain, Sweden and the UK) and the USA. A total of 1400 people, 700 men aged 50-70 years and 700 women aged >/=30 years with a partner or close male relative aged 40-70 years, completed a 10-minute telephone interview during which they answered questions about prostate cancer. RESULTS: When asked about types of cancers, the majority of female respondents (79%) mentioned breast cancer but less than half of the male respondents (39%) mentioned prostate cancer. Urinary problems were identified as a symptom of prostate cancer by 86% of respondents, but only 1% of the sample was aware that the disease could be asymptomatic. Half of all respondents were unaware of the use of simple tests to detect early prostate cancer and only 25% mentioned the prostate-specific antigen test. Awareness of hormone therapy for early prostate cancer was relatively low (23%), while awareness of watchful waiting was almost negligible (1%). CONCLUSIONS: This contemporary survey, the largest study of prostate cancer awareness ever undertaken and the first to provide an international perspective, clearly demonstrates the lack of awareness of prostate cancer among the general population and highlights the need for health education campaigns focusing on the disease.
OBJECTIVES: To assess the level of awareness of prostate cancer among the general public in Europe and the USA. METHODS: An independent survey was undertaken across six European countries (France, Germany, Italy, Spain, Sweden and the UK) and the USA. A total of 1400 people, 700 men aged 50-70 years and 700 women aged >/=30 years with a partner or close male relative aged 40-70 years, completed a 10-minute telephone interview during which they answered questions about prostate cancer. RESULTS: When asked about types of cancers, the majority of female respondents (79%) mentioned breast cancer but less than half of the male respondents (39%) mentioned prostate cancer. Urinary problems were identified as a symptom of prostate cancer by 86% of respondents, but only 1% of the sample was aware that the disease could be asymptomatic. Half of all respondents were unaware of the use of simple tests to detect early prostate cancer and only 25% mentioned the prostate-specific antigen test. Awareness of hormone therapy for early prostate cancer was relatively low (23%), while awareness of watchful waiting was almost negligible (1%). CONCLUSIONS: This contemporary survey, the largest study of prostate cancer awareness ever undertaken and the first to provide an international perspective, clearly demonstrates the lack of awareness of prostate cancer among the general population and highlights the need for health education campaigns focusing on the disease.
Authors: Rowan G Casey; David J Rea; Ted McDermott; Ronald Grainger; Michael Butler; J A Thornhill Journal: J Cancer Educ Date: 2012-03 Impact factor: 2.037
Authors: Rosalina Richards; Bronwen McNoe; Ella Iosua; Anthony I Reeder; Richard Egan; Louise Marsh; Lindsay Robertson; Brett Maclennan; Anna TF Latu; Robin Quigg; Anne-Cathrine Petersen Journal: Asian Pac J Cancer Prev Date: 2017-11-26
Authors: C Metcalfe; S Evans; F Ibrahim; B Patel; K Anson; F Chinegwundoh; C Corbishley; D Gillatt; R Kirby; G Muir; V Nargund; R Popert; R Persad; Y Ben-Shlomo Journal: Br J Cancer Date: 2008-09-16 Impact factor: 7.640
Authors: Tobias Nordström; Jan Chandra Engel; Martin Bergman; Lars Egevad; Markus Aly; Martin Eklund; Thorgerdur Palsdottir; Henrik Grönberg Journal: Eur Urol Open Sci Date: 2021-01-01